Ki-67-positive cells in each group were scored, and 6.98% and 6.84% of total tumor cells were calculated in the untreated group and hesperidin-treated group, whereas the proportions were 11.21% in the gallic acid-treated group and 4.84% in combination-treated spheroids (Figure 6E). The gene discussed is MKI67; the disease is neoplasm.